FARAH DOXEY: Open Payments
NPI 1750820791 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 16 payments from 6 companies in 2025. Trend: 2023 $93 · 2024 $603 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $189 |
| Eisai Inc. | 3 | $85 |
| Janssen Biotech, Inc. | 3 | $58 |
| IMMUNITYBIO, INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: KEYTRUDA, Lenvima, ERLEADA, LYNPARZA, ANKTIVA, Padcev, KEYTRUDA QLEX, ORGOVYX.
Industry payments across IN — which companies pay providers there.
